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Smooth muscle cellsThe forkhead box m1 (Foxm1 or Foxm1b) transcription factor (previously called HFH-11B, Trident, Win, or
MPP2) is expressed in a variety of tissues during embryogenesis, including vascular, airway, and intestinal
smooth muscle cells (SMCs). Although global deletion of Foxm1 in Foxm1−/− mice is lethal in the
embryonic period due to multiple abnormalities in the liver, heart, and lung, the speciﬁc role of Foxm1 in
SMC remains unknown. In the present study, Foxm1 was deleted conditionally in the developing SMC
(smFoxm1−/− mice). The majority of smFoxm1−/− mice died immediately after birth due to severe
pulmonary hemorrhage and structural defects in arterial wall and esophagus. Although Foxm1 deletion did
not inﬂuence SMC differentiation, decreased proliferation of SMC was found in smFoxm1−/− blood vessels
and esophagus. Depletion of Foxm1 in cultured SMC caused G2 arrest and decreased numbers of cells
undergoing mitosis. Foxm1-deﬁciency in vitro and in vivo was associated with reduced expression of cell
cycle regulatory genes, including cyclin B1, Cdk1-activator Cdc25b phosphatase, Polo-like 1 and JNK1
kinases, and cMyc transcription factor. Foxm1 is critical for proliferation of smooth muscle cells and is
required for proper embryonic development of blood vessels and esophagus.
© 2009 Elsevier Inc. All rights reserved.Introduction
Embryonic development of blood vessels depends on proper
vasculogenesis (formation of blood vessels de novo) and angiogenesis
(branching of preexisting blood vessels). While the majority of
vascular cell types develop from the mesoderm (Saint-Jeannet et al.,
1992), smooth muscle cells (SMC) may arise from multiple origins,
including mesodermal cells, neural crest cells, hematopoietic stem
cells, pericytes, and endothelial cells (Thayer et al., 1995; Gittenber-
ger-de Groot et al., 1999; Hao et al., 2003). In contrast to terminally
differentiated skeletal and cardiacmuscle cells, mature SMC retain the
ability to change their phenotype in response to changing environ-
ment conditions (Halayko and Solway, 2001). Several signaling path-
ways are critical for proper development of blood vessels, including
vascular endothelial growth factor (VEGF), angiopoietins, transform-
ing growth factor β (TGF-β), ﬁbroblast growth factors (FGFs),
platelet-derived growth factor (PDGF), Ephrin/Eph receptor, Sonic
hedgehog (Shh)/Patch, and Delta-ligand/Notch-receptors (Carmeliet
et al., 1996; Rossant and Howard, 2002; Chi et al., 2007), as well as
both canonical (Wnt7b) and Ca2+-dependent (Wnt4) Wnt signaling
pathways (Shu et al., 2002; Itaranta et al., 2006). These signalingiology, Cincinnati Children's
09, Cincinnati, OH 45229, USA.
V.V. Kalinichenko).
ll rights reserved.proteins regulate proliferation, differentiation, and migration of SMC
in the vascular wall by inducing expression of transcription factors
critical for regulation of SM-speciﬁc gene promoters. These transcrip-
tion factors include the serum response factor (SRF), myocardin, and
myocardin-related transcriptional factors that act as SRF activators to
induce expression of SRF target genes (Wang et al., 2001; Camoretti-
Mercado et al., 2003; Pipes et al., 2006). Development of blood vessels
also depends on MEF2B, P311 (C5orf13), MRF2 (ARID5B), and GATA4
transcription factors that are essential for differentiation of mesench-
ymal cells toward SMC cell lineage (Katoh et al., 1998; Belaguli et al.,
2000; Pan et al., 2002; Watanabe et al., 2002; Kumar and Owens,
2003).
The forkhead box (Fox) proteins are an extensive family of trans-
cription factors that share homology in the Winged Helix/Forkhead
DNA binding domain (Clark et al., 1993; Clevidence et al., 1993;
Kaestner et al., 1993). Foxm1 transcription factor (previously known
as HFH-11B, Trident, Win, or MPP2) is expressed in all tissues during
embryogenesis but its expression in adult mice is restricted to
intestinal crypts, thymus, and testes (Korver et al., 1997; Ye et al.,
1997). During organ injury, Foxm1 expression is induced in a variety
of cell types, including epithelial, endothelial, and smoothmuscle cells
(Ye et al., 1997; Kalinichenko et al., 2003). Foxm1 expression is
increased in tumor cells during progression of liver, lung, colon, and
prostate cancers (Kalinichenko et al., 2004; Kalin et al., 2006; Kim
et al., 2006; Yoshida et al., 2007). In our previous studies, we
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day 13.5 (E13.5) and E16.5 due to multiple abnormalities in
development of the embryonic liver, lung, and heart (Krupczak-Hollis
et al., 2004; Kim et al., 2005a; Ramakrishna et al., 2007). Abnormal
accumulation of polyploid cells, resulting from diminished DNA
replication and failure to enter mitosis, was observed in these
Foxm1−/− mouse organs (Korver et al., 1998; Krupczak-Hollis et al.,
2004; Ramakrishna et al., 2007). Foxm1 is required for differentiation
of hepatoblast precursor cells toward the biliary epithelial cell lineage,
and Foxm1−/− livers fail to form intrahepatic bile ducts (Krupczak-
Hollis et al., 2004). Likewise, Foxm1−/− embryos exhibit defects in
differentiation of pulmonary mesenchyme into mature capillary
endothelial cells during the canalicular stage of lung development
(Kim et al., 2005a).
Given the importance of Foxm1 for differentiation and prolifera-
tion of many cell lineages during embryonic development, organ
injury and carcinogenesis, several recent studies began to address
cell-speciﬁc roles of Foxm1 using conditional knockout mouse
models. Hepatocyte-speciﬁc deletion of Foxm1 in albumin-Cre
Foxm1ﬂ/ﬂ mice prevented formation of hepatocellular carcinoma
(HCC) in adult mice by inducing p27kip1 tumor suppressor in HCC
tumor cells and normal hepatocytes (Kalinichenko et al., 2004). In
response to the inﬂammatory mediator LPS, mice with endothelial-
speciﬁc Foxm1 deletion (Tie2-Cre Foxm1ﬂ/ﬂ mice) displayed signi-
ﬁcantly increased lung vascular permeability and markedly increased
mortality (Zhao et al., 2006). A conditional deletion of Foxm1 from
precursors of cerebellar granule neurons caused a delay in brain
development by interfering with Shh-induced neuroproliferation
(Ueno et al., 2008). Mice with pancreatic-speciﬁc deletion of Foxm1
displayed severe abnormalities in postnatal β-cell mass expansion,
causing impaired islet function and diabetes by 9 week of age (Zhang
et al., 2006). These mice also exhibited speciﬁc impairments in β-cell
mass regeneration and islet growth after partial pancreatectomy,
with reduced proliferation of α and β cells but no impairments in
acinar or ductal cell proliferation (Ackermann Misfeldt et al., 2008).
In our recent studies (Kalin et al., 2008), Foxm1 was deleted
conditionally in the respiratory epithelium during lung development
(SPC-rtTA/TetO-Cre Foxm1ﬂ/ﬂ mice). Deletion of Foxm1 in the respi-
ratory epithelium did not alter epithelial proliferation but inhibited
lung maturation and caused respiratory failure after birth (Kalin
et al., 2008). Maturation defects in Foxm1-deﬁcient lungs were
associated with a delay of type I cell differentiation and decreased
expression of surfactant-associated proteins A, B, C, and D, indicating
that Foxm1 is critical for surfactant homeostasis and lung maturation
prior to birth and is required for adaptation to air breathing (Kalin
et al., 2008). Although Foxm1 plays distinct roles in differentiation
and proliferation in various cell lineages, the speciﬁc role of Foxm1 in
smooth muscle cells remains unknown.
In this study, we usedmouse embryos to demonstrate that Foxm1 is
expressed in vascular smoothmuscle and airway smoothmuscle cells as
well as in smoothmuscle layers of esophagus, stomach and intestine. To
investigate the role of Foxm1 in smooth muscle cells in vivo, we
generated transgenic mice in which Foxm1-ﬂoxed allele was con-
ditionally deleted using Cre recombinase transgene driven by a smooth
muscle myosin heavy chain promoter (smMHC-Cre Foxm1ﬂ/ﬂ, or
smFoxm1−/−mice). We demonstrated that a majority of smFoxm1−/−
mice died immediately after birth due to severe pulmonary hemor-
rhage, structural defects in arterial wall, and esophageal abnormal-
ities. Although Foxm1 deletion did not inﬂuence differentiation of
smooth muscle cells, decreased cellular proliferation was observed in
muscle layers of embryonic blood vessels and esophagus. In vitro
experiments demonstrated that siRNA-mediated depletion of Foxm1
in cultured smooth muscle cells caused G2 arrest and decreased
numbers of cells undergoing mitosis. Depletion of Foxm1 in vitro and
in vivowas associated with reduced expression of cell cycle regulatory
genes, including cyclin B1, Cdk1-activator Cdc25b phosphatase, Polo-like 1 and JNK1 kinases, and cMyc transcription factor. Our studies
suggest that Foxm1 is required for proper development of blood
vessels and esophagus by regulating smooth muscle genes essential
for the cell cycle regulation.
Materials and methods
Mouse strains
We previously described the generation of Foxm1ﬂox/ﬂox
(Foxm1ﬂ/ﬂ) mice, which contain LoxP sequences ﬂanking DNA
binding and transcriptional activation domains of the Foxm1 gene
(Krupczak-Hollis et al., 2004). The Foxm1ﬂ/ﬂ mice were bred for 10
generations into C57Bl/6 mouse genetic background. The Foxm1ﬂ/ﬂ
female mice were bred with smMHC-Cre-GFPtg/− C57Bl/6 male mice
(obtained from Dr. Kotlikoff, Cornell University; Xin et al., 2002) to
generate the smMHC-Cre-GFPtg/− Foxm1ﬂ/ﬂ double-transgenic mice
(smooth muscle-speciﬁc Foxm1 knockout mice or smFoxm1−/−).
Although a majority of smFoxm1−/− embryos died immediately
after birth, 13% of smFoxm1−/− mice survived through birth and
were capable of mating. Foxm1ﬂ/ﬂ littermates lacking the smMHC-
Cre-GFP transgene were used as controls. Further controls included
double-heterozygous smMHC-Cre-GFPtg/− Foxm1ﬂ/+ mice. No
embryonic abnormalities were observed in control mice. smMHC-
Cre-GFPtg/− Foxm1ﬂ/ﬂ mice were bred with either TOPGAL trans-
genic mice (obtained from J. Whitsett's lab, Cincinnati Children's
Hospital Medical Center) or R26R reporter mice (Rosa26-LoxP-stop-
LoxP-β-galactosidase mice; purchased from Jackson Lab) to study
canonical Wnt signaling or Cre-mediated recombination, respec-
tively. Animal studies were reviewed and approved by the Animal
Care and Use Committee of Cincinnati Children's Hospital Research
Foundation.
Immunohistochemical staining, in situ hybridization, and laser capture
microdissection
smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos were harvested, ﬁxed
overnight with 10% buffered formalin, and then embedded into
parafﬁn blocks. Parafﬁn 5 μm sections were either used for
immunohistochemistry or stained with hematoxylin and eosin
(H&E) for morphological examination as described (Kim et al.,
2005b). The following antibodies were used for immunostaining:
Cre (1:25,000; No. 69050-3; Novagen), Ki-67 (1:500; clone Tec-3;
Dako), GFP (1:15,000; clone JL-8; Clontech), activated caspase 3
(1:200; 5A1; Cell Signaling),α-smoothmuscle actin (α-SM; 1:15,000;
clone 1A4; Sigma), γ-smooth muscle actin (γ-SM; 1:500; clone B4;
Seven Hills Bioreagents, Cincinnati, OH), smooth muscle calponin
(1:5000; clone hCP; Sigma), smooth muscle myosin heavy chain
(1:250; clone HSM-V; Sigma), Pecam-1 (1:300; clone MEC 13.3;
Pharmingen), Foxa2 (1:2000; Seven Hills Bioreagents, Cincinnati,
OH), proSPC (1:1500; AB-3428; Chemicon International), CCSP
(1:1000; a gift from Dr. Stripp, Duke University), and MyoD (1:20;
NCL-MyoD1; Vision Bio Systems Novocastra). Antibody–antigen
complexes were detected using biotinylated secondary antibody
followed by avidin–horseradish peroxidase (HRP) complex, and DAB
substrate (Vector Labs, Burlingame, CA). Sections were counter-
stainedwith nuclear fast red. For co-localization experiments, parafﬁn
sections were stained with FITC-labeled α-SM antibodies (green
ﬂuorescence) followed by immunostaning with antibodies against
either cleaved caspase 3 or Ki-67 that were detected by TRITC-labeled
secondary antibodies (red ﬂuorescence). DAPI was used as a counter-
stain. Fluorescent images were obtained using a Zeiss Axioplan2
microscope equipped with an AxioCam MRm digital camera and
AxioVision 4.3 Software (Carl Zeiss Microimaging, Thornwood, NY).
Parafﬁn sections were also used for in situ hybridization with 35S-
labeled antisense riboprobe speciﬁc to 1649–1947 bp region of the
Table 1
TaqMan gene expression assays (Applied Biosystems) were used for qRT–PCR analysis.
Mouse Foxm1 Mm00514924_m1
Mouse cyclin B1 Mm00838401_g1
Mouse Cdc25B Mm00499136_m1
Mouse cyclin D1 Mm00432359_m1
Mouse c-Myc Mm00487804_m1
Mouse JNK1 Mm00489514_m1
Mouse beta-actin Mm00607939_s1
Human Foxm1 Hs00153543_m1
Human cyclin B1 Hs00259126_m1
Human Plk1 Hs00153444_m1
Human cyclin D1 Hs00277039_m1
Human c-Myc Hs00153408_m1
Human JNK1 Hs00177083_m1
Human beta-actin Hs99999903_m1
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E16.5 sections to perform laser capture microdissection of aortic
tissue in smFoxm1−/− and control Foxm1ﬂ/ﬂ mice. The Veritas
Microdissecting System (Molecular Devices, Sunnyvale, CA) was
used for the laser capture microdissection experiments accordingly
to protocols supplied by the manufacturer.
siRNA transfection, ﬂow cytometry, and PH3 staining in cultured
HAVSMC cells
Human aortic vascular smooth muscle cells (ATCC cell line T/G
HA-VSMC) were cultured in F-12K medium with supplements
recommended by ATCC. In order to inhibit Foxm1 expression in
HAVSMC cells, we used a 21-nucleotide short-interfering RNA
(siRNA) duplex speciﬁc to 1066–1084 nucleotide region of the
human Foxm1 cDNA (siFoxm1, 5′-gga cca cuu ucc cua cuu u-3′).
Foxm1 siRNA containing symmetric 2-Uracil (U) 3′ overhangs was
designed and synthesized using Dharmacon Research algorithm
(Kim et al., 2006). We transfected 100 nM of either siFoxm1 or
mutant siFoxm1 (mutFoxm1; mutated nucleotides are indicated by
capital letters, 5′-gga ccU GuA uGc Gua cAu u-3′) duplexes into human
HAVSMC cells using Lipofectamine™ 2000 reagent (Invitrogen) in
serum-free tissue culture media as described previously (Wang et al.,
2005a; Kim et al., 2006). HAVSMC cells were harvested at 72 hr after
transfection for total RNA preparation or propidium iodide (PI)
staining. PI-stained HAVSMC cells were analyzed by ﬂow cytometry to
determine numbers of cells in different stages of the cell cycle as
described previously (Wang et al., 2005a). The ﬂow cytometry and
analysis were performed in the ﬂow cytometry core facility of
Cincinnati Children's Hospital Research Foundation. In separate
experiments, HAVSMC cells undergoing either G0/G1 or G2/M phase
of the cell cycle were identiﬁed using Vybrant DyeCycle™ Violet stain
(Invitrogen) according to the manufacturer's recommendations.
Stained cells were sorted using a 5-laser FACSAria II ﬂow cytometer
(BD Biosciences). The cells in G0/G1 and G2/M phase were harvested
into collection tubes ﬁlled with RLT RNA lysis buffer, and then used to
prepare total RNA. For PH3 staining, siRNA-transfected HAVSMC cells
were ﬁxed with 10% buffered formalin and immunostained with
antibodies against phospho-Histone H3 (PH3; 1:100 dilution; No. 06-
570; Upstate) to visualize cells undergoing mitosis as described
(Wang et al., 2005a).
Affymetrix cDNA array analysis and quantitative real-time RT–PCR
(qRT–PCR)
Total RNAwas prepared from either siFoxm1-transfected or mock-
transfected HAVSMC cells using RNA-STAT-60 (Tel-Test “B” Inc.
Friendswood, TX). Synthesis of human HAVSMC cDNAs with CyDye
nucleotides (Cy3 and Cy5), hybridization of Affymetrix GeneChip®
Human Genome U133 plus 2.0 array, scanning, and analysis of cDNA
Microarrays were performed by the Functional Genomics Facility at
the University of Chicago (Chicago, IL). Data were deposited to GEO
public database (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE17543; accession no. GSE17543). Data were analyzed usingFig. 1. Deletion of Foxm1 in smooth muscle cells. (A–H) Foxm1 expression in smooth mus
(E, F), E15.5 embryos (A–D), or adult mice (G–H) were used for in situ hybridizati
counterstained with toluidine blue. During embryogenesis, Foxm1 is expressed in all ce
artery; Tr, trachea; Es, esophagus; In, intestine. In adult mice, Foxm1 expression is restrict
deletion in Foxm1-ﬂoxed gene. To delete Foxm1 in smooth muscle cells, Foxm1ﬂ/ﬂ mice
double-transgenic mice, containing a deletion of exons 4–7 of the mouse Foxm1 gene (s
allele and smMHC-Cre-GFP transgene. L-Q, Cre recombination in smooth muscle cells of sm
(Br), and intestine (In) of smFoxm1−/−/R26R E15.5 embryos. The Foxm1 mutants displaye
and right ventricles (RV). β-Gal activity was not detected in control Foxm1ﬂ/ﬂ/R26R em
speciﬁcally expressed in smFoxm1−/− smooth muscle cells. Parafﬁn sections from Foxm1ﬂ
GFP antibody (R and S). Magniﬁcations: Q, ×50; A and B and E–H, ×100; C–D, N–O, andGenespring 7.2 (Silicon Genetics). A volcano plot was used to identify
signiﬁcance and magnitude of gene expression changes with a
minimum set as 2-fold as previously described (Dave et al., 2006).
Gene expression proﬁle was also subjected to an additional ﬁlter and
classiﬁed according to Gene Ontology classiﬁcation on Biological
Process using the publicly available web-based tool David (database
for annotation, visualization, and integrated discovery) (Dennis et al.,
2003). The Fisher exact test was used to calculate the probability of
each gene ontology category among all genes included in the array. To
avoid individual variations, we combined 10 μg of RNA from three
distinct HAVSMC cell cultures for each group. Expression levels of 421
genes were decreased N2.0-fold in siFoxm1-transfected cells com-
pared to mock-transfected HAVSMC cells. Expression levels of 27
genes were increased N2.0-fold in siFoxm1-transfected cells.
To verify expression levels of selected genes, we performed qRT–
PCR analysis using a StepOnePlus Real-Time PCR system (Applied
Biosystems, Foster City, CA) as described (Kalin et al., 2008).
Samples were ampliﬁed with TaqMan Gene Expression Master Mix
(Applied Biosystems) combined with inventoried TaqMan gene
expression assays for the gene of interest (Table 1). Reactions were
analyzed in triplicates and expression levels were normalized to β-
actin. Total RNA was also prepared from laser-captured E16.5 aortic
tissue of either smFoxm1−/− or control Foxm1ﬂ/ﬂ embryos and then
analyzed by qRT–PCR. Three embryos were used in each group.
Statistical analysis
Student's T-test was used to determine statistical signiﬁcance.
P values≤0.05 were considered signiﬁcant. Values for all measure-
ments were expressed as the mean±standard deviation (SD).
Results
Conditional deletion of Foxm1 in smooth muscle cells causes a
perinatal lethality
Previous studies have demonstrated that Foxm1 is expressed in a
variety of cell types during embryogenesis (Ye et al., 1997; Kalin et al.,cle cells during mouse embryonic development. Parafﬁn sections from E13.5 embryos
on with 35S-labeled antisense riboprobe speciﬁc to mouse Foxm1. Sections were
ll types, including smooth muscle (sm) and epithelial cells (ep). Abbreviations: Ar,
ed to epithelial cells (ep) of intestinal crypts. (I) Schematic drawing of Cre-mediated
were bred with smMHC-Cre-GFPtg/− mice to generate smMHC-Cre-GFPtg/− Foxm1ﬂ/ﬂ
mFoxm1−/− mice). (J and K) PCR analysis of genomic DNA identiﬁed Foxm1-ﬂoxed
Foxm1−/− mice. β-Gal activity was observed in arteries (Ar), esophagus (Es), bronchi
d a mosaic Cre recombination in left (LA) and right atriums (RA) but not in left (LV)
bryos. Sections were counterstained with nuclear fast red. (R–W) Cre transgene is
/ﬂ and smFoxm1−/− E15.5 embryos were stained with either Cre antibody (T–W) or
T–W, ×200; remaining panels, ×400.
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cells, in situ hybridization was performed with Foxm1-speciﬁc
antisense riboprobe. In E15.5 mouse embryos, Foxm1 mRNA was
detected in vascular smooth muscle cells of arteries (Figs. 1A–C) aswell as in smooth muscle cells underlying the developing esophagus,
trachea, bronchi, stomach, and intestine (Figs. 1A–F and data not
shown). In adult mice, Foxm1 expression was observed in epithelium
of intestinal crypts (Figs. 1G and H). Foxm1mRNAwas not detected in
Table 2
Breeding data for smFoxm1−/− mice.
Developmental
period
Total
number
of mice
Expected % of
smFoxm1−/−
mice
Experimental %
(number) of alive
smFoxm1−/− mice
% mortality in
smFoxm1−/−
mice
E15.5–E16.5 36 50% 47% (17) (all alive) 0%
E17.5–E18.5 75 50% 53% (40) (all alive) 0%
Postnatal day 1 98 50% 6% alive (6) 87%
47% dead (46)
Breeding data from smMHC-Cre GFPtg/− Foxm1ﬂ/ﬂ × Foxm1ﬂ/ﬂmouse crosses are shown
as a frequency of occurrence of smMHC-Cre GFPtg/− Foxm1ﬂ/ﬂ mice (smFoxm1−/−).
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mice (Figs. 1G and H and data not shown). These data demonstrate
that Foxm1 is expressed in different populations of smooth muscle
cells during embryonic development but its expression is extin-
guished in adult smooth muscle cells.
To determine whether Foxm1 is required for smooth muscle
cells during embryonic development, we generated double-trans-
genic mice containing LoxP-ﬂanked exons 4–7 of the Foxm1 gene
(Foxm1ﬂ/ﬂ) and Cre recombinase transgene driven by smooth
muscle myosin heavy chain promoter (smMHC-Cre-GFP; Xin et al.,
2002). Previous studies demonstrated that using this smMHC-Cre-
GFP transgenic mouse line, Cre-mediated recombination occurs in
all populations of smooth muscle cells beginning from E12.5 (Xin
et al., 2002). The smooth muscle-speciﬁc expression of Cre
recombinase causes deletion of exons 4, 5, 6, and 7, which encode
the DNA binding and transcriptional activation domains of the
Foxm1 protein (Fig. 1I), to produce smooth muscle-speciﬁc Foxm1
knockout mice (smMHC-Cre-GFPtg/−/Foxm1ﬂ/ﬂ or smFoxm1−/−). In
smFoxm1−/− newborn mice, body weight and lung-to-body weight
ratio were unchanged (data not shown). However, deletion of
Foxm1 caused a perinatal lethality in 87% of smFoxm1−/− mice
within the ﬁrst 24 hr after birth (Table 2). No perinatal lethality was
observed in control Foxm1ﬂ/ﬂ littermates or double-heterozygous
smMHC-Cre-GFPtg/−/Foxm1ﬂ/+ newborn mice (data not shown).
When assessed prior to birth, smFoxm1−/− embryos were present
as Mendelian inheritance (Table 2), indicating that the Foxm1
function in smooth muscle cells was not required for fetal survival
in utero but was critical for survival immediately after birth.
To determine whether Cre recombination in smFoxm1−/− em-
bryos occurred prior to the perinatal lethality, we bred smFoxm1−/−
mice with R26R reporter mice to generate smFoxm1−/−/R26R
embryos, which were stained for β-galactosidase (β-gal) activity.
Although β-gal activity was not detected in control Foxm1ﬂ/ﬂ/R26R
embryos at E15.5 (Fig. 1L), β-gal activity was observed in Foxm1-
deﬁcient smooth muscle cells of E15.5 arteries, esophagus, stomach,
trachea, bronchi, and intestine (Figs. 1M–P and data not shown).
Furthermore, to detect the presence of Cre protein in smooth muscle
cells, smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos were immunos-
tained with antibodies against Cre recombinase. Although Cre was
not expressed in Foxm1ﬂ/ﬂ embryos (Fig. 1T), Cre protein was
detected in smooth muscle cells surrounding esophagus, stomach,
intestine, and pulmonary airways of E15.5 smFoxm1−/− embryos
(Figs. 1U–W and data not shown), which is consistent with β-gal
activity in smFoxm1−/−/R26R embryos (Figs. 1L–P). Finally, speciﬁc
expression of Cre transgene in smFoxm1−/− smooth muscle cells was
also conﬁrmed by immunostaining with antibodies against GFP (Figs.
1R and S and data not shown), a reporter protein expressed under
control of smMHC promoter in smFoxm1−/− embryos (Fig. 1I).
Altogether, these results demonstrate that both Cre-mediated
recombination and expression of Cre transgene occurred in smooth
muscle cells of smFoxm1−/− embryos prior to perinatal lethality.
Interestingly, although a mosaic Cre recombination was detected in
atriums of Foxm1 mutant hearts as wells as in cardiac regions
directly adjacent to aorta and pulmonary trunk, no structural abnor-malities were observed in these heart regions (Fig. 1Q and data not
shown).
Foxm1 is required for development of esophagus
Since Foxm1 is expressed in esophageal, bronchial and intestinal
muscle layers (Figs. 1A–F), histological analysis of these organs was
performed in smFoxm1−/− embryos. Embryonic esophageal muscle is
composed of outer longitudinal and inner circumferential layers, both
of which express Cre recombinase transgene in smFoxm1−/− mutant
mice (Figs. 1M and V). Histological structure of esophagus was similar
in smFoxm1−/− and control Foxm1ﬂ/ﬂ littermates at E15.5 (Figs. 2A
and B). At E18.5, esophageal muscle in smFoxm1−/− mutants
appeared underdeveloped, and a progressive loss of mesenchymal
cells became apparent (Figs. 2E and J). Signiﬁcantly diminished thick-
ness of esophageal muscle was found in smFoxm1−/− E18.5 embryos
(Fig. 2V). No structural abnormalities were observed in either
Foxm1ﬂ/ﬂ or smMHC-Cre-GFPtg/− embryos (Figs. 2C, D and H, I). In
smFoxm1−/− newborn mice, the entire esophagus contained very
thin muscular layers fused together (Figs. 2F, G). The structural
abnormalities of the esophagus can interfere with proper functions
of the gastrointestinal system, contributing to perinatal lethality in
smFoxm1−/− newborn mice. Interestingly, no intestinal, bronchial,
or stomach defects were found in smFoxm1−/− embryos or newborn
mice (Figs. 2K–O and P–R), indicating different requirements in
Foxm1 function in different populations of developing smooth
muscle cells. Finally, normal expression of CCSP (Clara cell marker)
and proSPC (type II cell marker) was observed in smFoxm1−/− E18.5
airways when compared to either Foxm1ﬂ/ﬂ or smMHC-Cre-GFPtg/−
embryos (Figs. 2P–U). These results suggest that Foxm1 deﬁciency
does not inﬂuence the development of different populations of
epithelial cells in pulmonary airways.
Foxm1 is required for proper development of blood vessels
Histological examination of the smFoxm1−/− newborn mice
revealed extensive pulmonary hemorrhage with red blood cells
present in bronchioles and peripheral pulmonary saccules (Figs. 3A
and B). Pulmonary arteries from smFoxm1−/− mice displayed multi-
ple hernias in arterial walls, disruption of vascular muscle layers, and
accumulation of large cells with round nuclei (Figs. 3G–L), the latter of
which is a hallmark of Foxm1 deﬁciency (Korver et al., 1998;
Krupczak-Hollis et al., 2004; Ramakrishna et al., 2007). Morphological
evidence of vascular leakage from perforated pulmonary arteries was
also detected in smFoxm1−/− newborn mice (Figs. 3E and F). Thus,
the structural abnormalities of the arterial wall can compromise
vascular integrity and contribute to perinatal lethality in smFoxm1−/−
newborn mice. Interestingly, hemorrhage was not observed in the
liver, gut, brain, and skeletal muscle of the smFoxm1−/− newborn
mice, and the heart structure in smFoxm1−/− mice was normal (data
not shown). Since lung hemorrhage was not detected in smFoxm1−/−
mutants prior to birth (data not shown), these results indicate that
the hemorrhaging phenotype was concomitant with the increased
pulmonary arterial blood ﬂow that occurs following birth.
Published studies demonstrated that Wnt7b−/− mice displayed
extensive pulmonary hemorrhage, perinatal lethality, and structural
abnormalities in vascular smooth muscle (Shu et al., 2002), a pheno-
type similar to smFoxm1−/−mice (Figs. 3A–L). The vascular defects in
Wnt7b−/− mice were attributed to a disruption of canonical Wnt
signaling in vascular smooth muscle cells (Shu et al., 2002; Wang
et al., 2005b). Therefore, the vascular abnormalities in smFoxm1−/−
mutants could occur due to diminished activity of canonical Wnt
signaling pathway. To visualize the canonicalWnt signaling in Foxm1-
deﬁcient embryos, we bred smFoxm1−/− mice with TOPGAL trans-
genic mice to produce TOPGALtg/−/smFoxm1−/− embryos. The
TOPGALtg/−/smFoxm1−/− embryos were stained for β-gal activity
Fig. 2. Esophageal defects in smFoxm1−/− mice. (A–O) Esophageal defects in Foxm1-deﬁcient mice. Parafﬁn sections from smFoxm1−/−, Foxm1ﬂ/ﬂ, and smMHC-Cre-GFPtg/−
embryos were stained with hematoxylin and eosin (H&E). Histological structure of esophagus (Es) was similar in smFoxm1−/− and control Foxm1ﬂ/ﬂ littermates at E15.5 (A and B).
Thinning of esophageal muscle (sm) and loss of mesenchymal cells (me) were observed in smFoxm1−/− E18.5 embryos (C–E and H–J) and newborn mice (F–G). No structural
defects were observed in smFoxm1−/− stomach (K–L) and intestine (M–O). (P–U) Normal expression of CCSP and proSPC epithelial marker proteins in Foxm1-deﬁcient lungs.
Staining was visualized using biotinylated secondary antibody, avidin–HRP, and DAB substrate (dark brown), and then counterstained with nuclear fast red. (V) Diminished
thickness of esophageal muscle is observed in smFoxm1−/− E18.5 embryos. Means±SD were determined using three different smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos (10
random sections for each embryo). A P valueb0.05 is shown with asterisk. Abbreviations: Es, esophagus; In, intestine; St, stomach; Br, bronchiole; ep, epithelial cells. Magniﬁcation:
A and B, ×200; H–J and P–U, ×400; remaining panels, ×100.
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E12.5 and E13.5 embryos, β-gal activity was detected in pulmonary
arteries, bronchi, stomach, cartilage, and aortic outﬂow and
pulmonary trunks of the developing heart (Figs. 3M–T and data
not shown). Similar β-gal activity was observed in control and
Foxm1 mutant embryos (Figs. 3M–T). Thus, Foxm1 deletion from
smooth muscle cells does not alter canonical Wnt signaling during
embryogenesis.Foxm1 does not inﬂuence differentiation of smooth muscle cells
Recent studies demonstrated that Foxm1 regulates differentiation
of hepatoblasts, endothelial cells, and neural precursor cells in mouse
and Xenopus embryos (Krupczak-Hollis et al., 2004; Kim et al., 2005a;
Ueno et al., 2008). To determine the role of Foxm1 in differentiation of
smooth muscle cells, we used smFoxm1−/− embryos to examine
expression of smooth muscle marker proteins at E18.5. smFoxm1−/−
Fig. 3. Perinatal pulmonary hemorrhage and vascular defects in smFoxm1−/− mice. (A–L) Pulmonary hemorrhage in Foxm1-deﬁcient mice. Embryonic lungs from smFoxm1−/−,
Foxm1ﬂ/ﬂ, and smMHC-Cre-GFPtg/−mice were ﬁxed, parafﬁn-embedded, sectioned, and stained with hematoxylin and eosin (H&E). smFoxm1−/− newborn mice displayed extensive
pulmonary hemorrhage with red blood cells present in bronchioles and peripheral pulmonary saccules (A and B). No structural abnormalities were observed in either Foxm1ﬂ/ﬂ (C)
or smMHC-Cre-GFPtg/− blood vessels (D). Pulmonary arteries from smFoxm1−/−mice displayed tears in arterial walls and disruption of smooth muscle layers (F and E, shown with
arrows), multiple hernias (G, H, K, and L), as well as accumulation of large cells with round nuclei (I and J, shown with arrowheads). (M–T) Activity of canonical Wnt signaling
pathway in smFoxm1−/− embryos. TOPGALtg/−/smFoxm1−/− and control TOPGALtg/−/smFoxm1ﬂ/ﬂ embryos were stained for β-gal activity at E12.5 (M–P) and E13.5 (Q–T). Sections
were counterstained with nuclear fast red. Control and Foxm1 mutant embryos displayed similar β-gal activity (blue) in pulmonary arteries (pa), and bronchial epithelium (ep),
smooth muscle (sm), and cartilage (car) of bronchi (br), as well as in aortic outﬂow and pulmonary trunks of the developing heart. Abbreviations: LA, left atrium; RA, right atrium;
LV, left ventricle; RV, right ventricle. Magniﬁcation: A, B, M, O, Q and S, ×50; H, ×100; I–L, R, and T, ×400; remaining panels, ×200.
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the early (α-smoothmuscle actin (α-SM) and smooth muscle myosin
heavy chain (smMHC)) and the late markers of smooth muscle cells
(γ-smooth muscle actin (γ-SM) and smooth muscle-speciﬁc calponin
(smCalponin)) in embryonic blood vessels and pulmonary airways
(Fig. 4A). Furthermore, smFoxm1−/− and control Foxm1ﬂ/ﬂ esophagi
displayed similar expression pattern for both α-SM and γ-SM, both of
which were detected in three esophageal layers: an inner submucosal
layer directly adjacent to the epithelium, and two smooth musclelayers representing longitudinal and circumferential layers (Fig. 4B).
Expression of epithelial-speciﬁc marker Foxa2 and endothelial-
speciﬁc marker Pecam-1 was not changed in smFoxm1−/− esophagus
and artery, respectively (Figs. 4A and B). These results suggest that
Foxm1 deﬁciency does not inﬂuence the differentiation of smooth
muscle cells during embryonic development.
During embryogenesis, skeletal muscle contributes to the deve-
lopment of esophageal smooth muscle layers (Kablar et al., 2000;
Rishniw et al., 2003). To determine whether there was a normal
Fig. 4. smFoxm1−/− embryos displayed normal expression of smooth muscle marker proteins. E18.5 sections from smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos were stained with
antibodies against smooth muscle myosin heavy chain (smMHC), α-smooth muscle actin (α-SM-actin), γ-smooth muscle actin (γSM-actin), smooth muscle-speciﬁc calponin
(smCalponin), Cre recombinase (Cre), MyoD transcription factor, Pecam-1, and Foxa2. Stainingwas visualized using biotinylated secondary antibody, avidin–HRP, and DAB substrate
(dark brown), and then counterstained with nuclear fast red. Similar expression of smooth marker proteins was observed in smFoxm1−/− and control Foxm1ﬂ/ﬂ arteries (A) and
esophagi (B) Abbreviations: Ar, artery; Br, bronchiole; ep, epithelial cells; sm, smooth muscle cells. Magniﬁcations: left panels in A, ×100; remaining panels, ×400.
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embryos were stained for the presence of skeletal muscle cells using
an antibody to the skeletal muscle-speciﬁc transcription factor MyoD.
Although smFoxm1−/− esophagi contained less MyoD-positive cells
compared to control Foxm1ﬂ/ﬂ embryos (Fig. 4B), no signiﬁcant
differences were observed in percentages of MyoD-positive cells
among total numbers of muscle cells in the developing esophagus
(data not shown). Thus, Foxm1 deﬁciency does not inﬂuence diffe-
rentiation of skeletal muscle in smFoxm1−/− esophagus.
Diminished smooth muscle proliferation in smFoxm1−/− embryos
Immunohistochemistry was used to compare cellular proliferation
and apoptosis in smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos. Rare
apoptosis was observed in newborn Foxm1ﬂ/ﬂ mice as demonstrated
by immunostaining with an antibody speciﬁc to activated form of
caspase 3 (Fig. 5A). In contrast, smFoxm1−/− newbornmice displayed
an increased apoptosis in the lung (Figs. 5B and C), pulmonary bloodvessels (Figs. 5E and F), and esophagus (Figs. 5H and I). Apoptosis was
observed in both myocytes (Fig. 5H) and other cell types directly
adjacent to muscle layers (Figs. 5F and I). Total numbers of caspase 3-
positive cells were signiﬁcantly increased in the lung of smFoxm1−/−
mice when compared to either Foxm1ﬂ/ﬂ or smMHC-Cre-GFPtg/− lungs
(Figs. 5J–L).
Cellular proliferation in smFoxm1−/− embryos was assessed by
immunostaning using antibody against the cell proliferation marker
Ki-67. In control Foxm1ﬂ/ﬂ and smMHC-Cre-GFPtg/− embryos, Ki-67-
positive cells were readily detected in endothelial and smooth muscle
layers of the developing aorta, as well as in all layers of the developing
esophagus (Fig. 6A). Although cellular proliferation in epithelial cells
was normal, diminished Ki-67 staining was observed in smooth
muscle cells of smFoxm1−/− embryos (Figs. 6A and B). In comparison
to control embryos, total numbers of Ki-67-positive smooth muscle
cells were signiﬁcantly decreased in smFoxm1−/− blood vessels and
esophagi (Fig. 6C). These results demonstrated that Foxm1 deﬁciency
reduces cellular proliferation in developing smooth muscle cells.
Fig. 5. Increased apoptosis in newborn smFoxm1−/− mice. (A–I, K, and L) Increased apoptosis in smFoxm1−/− mice. Parafﬁn sections from newborn smFoxm1−/−, Foxm1ﬂ/ﬂ, and
smMHC-Cre-GFPtg/−mice were stained with antibodies against cleaved caspase 3 (dark brown, shownwith arrows) and counterstained with nuclear fast red (A–C, G–H, K, and L). In
colocalization experiments (D–F and I), parafﬁn sections were stained with antibodies against cleaved caspase 3 (red ﬂuorescence),α-SM-actin antibodies (green ﬂuorescence), and
DAPI (blue ﬂuorescence). Erythrocytes displayed yellow autoﬂuorescence. Rare apoptosis was observed in Foxm1ﬂ/ﬂ esophagus (G) and blood vessels (A and D) as well as in smMHC-
Cre-GFPtg/− embryos (K and L). smFoxm1−/−mice displayed an increased apoptosis in pulmonary blood vessels (B, C, and E), esophagus (H), as well as cells adjacent tomuscle layers
(F and I, shown with arrows). Abbreviations: Ar, Artery; Es, esophagus. Magniﬁcations: C, G, H, and L, ×200; remaining panels, ×400. (J) Increased number of apoptotic cells in
smFoxm1−/− newborns. Numbers of apoptotic cells in smFoxm1−/−, Foxm1ﬂ/ﬂ, and smMHC-Cre-GFPtg/− lungs were counted in ten random 100× microscope ﬁelds. Mean±SD was
determined using three different lungs in each group. A statistically signiﬁcant P valueb0.05 is shown with asterisk.
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In order to determine whether Foxm1 directly induces prolifera-
tion of smooth muscle cells in vitro, human aortic vascular smooth
muscle cells (HAVSMC) were transfected with short-interfering RNA
(siRNA) duplex speciﬁc to the human Foxm1 mRNA (siFoxm1) or
with mutant siFoxm1 duplex (mutFoxm1) containing ﬁve mutationsin the siRNA structure (Wang et al., 2005a; Kim et al., 2006). Seventy-
two hours later, cells were stained with propidium iodide (PI) and
examined for DNA content by ﬂow cytometry analysis. Foxm1
depletion in HAVSMC cells caused a signiﬁcant reduction in G0/G1-
phase cells and a decrease in mitotic progression as evidenced by a 2-
fold increase in G2/M phase (4N DNA content) with accumulation of
polyploid cells (Fig. 6D). To distinguish between G2 and M phases of
the cell cycle and to visualize cells undergoing mitosis, siRNA-
Fig. 6. Diminished cellular proliferation in smFoxm1−/− smooth muscle cells. (A and B) smFoxm1−/− embryos displayed diminished proliferation in smooth muscle cells. Parafﬁn
sections from smFoxm1−/−, Foxm1ﬂ/ﬂ, and smMHC-Cre-GFPtg/− E18.5 embryos were stained with Ki-67 antibody (dark brown nuclei) and counterstained with nuclear fast red (A).
In colocalization experiments (B), parafﬁn sections were stained with Ki-67 antibodies (red ﬂuorescence), α-SM-actin antibodies (green ﬂuorescence), and DAPI (blue
ﬂuorescence). Erythrocytes displayed yellow autoﬂuorescence. Diminished Ki-67 staining was selectively observed in smooth muscle cells (sm, shownwith arrows) of smFoxm1−/−
arteries (Ar) and esophagi (Es). Cellular proliferation was similar in endothelial (en) and epithelial cells (ep) of smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos. Magniﬁcation: ×400.
(C) smFoxm1−/− embryos exhibited a decreased number of Ki-67-positive smooth muscle cells. Percentages of Ki-67-stained smooth muscle nuclei were counted in 10 random
400× microscope ﬁelds from smFoxm1−/−, Foxm1ﬂ/ﬂ, and smMHC-Cre-GFPtg/− E18.5 embryos. Mean±SD was determined using three different embryos in each group. A
statistically signiﬁcant P valueb0.05 is shown with asterisk. (D) Flow cytometry analysis of Foxm1-depleted HAVSMC cells shows decreased G0/G1 phase and accumulation of G2/M
(4N) and polyploid cells (poly). HAVSMC cells were transfected with either siFoxm1 or mutant siRNA (siFoxm1) for 72 hr and then stained with propidium iodide and subjected to
ﬂow cytometry analysis. Graphically shown is the statistically signiﬁcant change in the percentage of cells accumulating in G0/G1 and G2/M (4N) compared to mock-transfected
cells. Means±SD are calculated from triplicate plates. (E) Foxm1 depletion diminishes the total number of HAVSMC cells undergoing mitosis. siRNA-transfected HAVSMC cells were
immunostained with PH3 antibodies to visualize cells undergoing mitosis. Mock-transfected or mutant siRNA-transfected HAVSMC cells were used as controls. Numbers of PH3-
positive cells are presented as means±SD from 10 random ×400 ﬁelds. Three cell cultures were used for each transfection.
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speciﬁc to phospho-histone H3 (PH3), a marker for mitotic cells.
Depletion of Foxm1 caused a 75% reduction in the number of PH3-
positive HAVSMC cells compared to either untransfected HAVSMC
cells or cells transfected with mutFoxm1 (Fig. 6E). These results
suggest that depletion of Foxm1 in cultured smooth muscle cells
caused a G2 arrest with accumulation of polyploid cells due to a
signiﬁcant decrease in mitotic progression.
Gene expression proﬁle in Foxm1-deﬁcient smooth muscle cells
In order to identify potential Foxm1-target genes in smoothmuscle
cells, we performed analysis of mouse Affymetrix microarrays that
were hybridized with cDNA probes synthesized from either siFoxm1-
transfected ormock-transfectedHAVSMCcells. This analysis identiﬁed
448 genes in which expression was either signiﬁcantly decreased(N2.0-fold, 421 genes) or increased (N2.0-fold, 27 genes) after the
Foxm1 depletion (see GEO database for a complete list of genes with
altered expression levels in siFoxm1-transfected HAVSMC cells;
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17543;
accession no. GSE17543). Differentially expressed genes in siFoxm1-
transfected HAVSMC cells were functionally classiﬁed according to
Gene Ontology (GO). Gene Ontology analysis was performed using
David (database for annotation, visualization, and integrated
discovery) (Dennis et al., 2003). “Mitosis” was the most signiﬁcantly
overrepresented process, which accounted for 22% of down-
regulated genes with a Fisher exact test P value of 1.54e−37
(Table 3). “Negative regulation of cellular processes” and “negative
regulation of apoptosis” were signiﬁcantly enriched in subset of up-
regulated genes (Table 3). In Table 4, we summarized our focus on
several known Foxm1 target genes as well as novel genes regulated
directly or indirectly by the Foxm1 protein.
Table 3
Functional classiﬁcation of up- and down-regulated genes.
Term Count % P value
Down-regulated genes
GO:0007067∼mitosis 38 22.22% 1.54e−37
GO:0000278∼mitotic cell cycle 42 24.56% 2.12e−37
GO:0000087∼M phase of mitotic cell cycle 38 22.22% 2.17e−37
GO:0022403∼cell cycle phase 42 24.56% 2.33e−35
GO:0000279∼M phase 39 22.81% 5.08e−35
GO:0007049∼cell cycle 54 31.58% 1.67e−31
GO:0022402∼cell cycle process 50 29.24% 7.05e−31
GO:0051301∼cell division 33 19.30% 3.29e−29
GO:0000074∼regulation of progression
through cell cycle
26 15.20% 2.14e−12
GO:0051726∼regulation of cell cycle 26 15.20% 2.42e−12
GO:0007017∼microtubule-based process 15 8.77% 5.65e−09
Up-regulated genes
GO:0048523∼negative regulation of cellular
process
10 19.61% 0.00174902
GO:0048519∼negative regulation of biological
process
10 19.61% 0.002343679
GO:0043066∼negative regulation of apoptosis 5 9.80% 0.002670858
GO:0043069∼negative regulation
of programmed cell death
5 9.80% 0.002798642
GO:0032502∼developmental process 16 31.37% 0.010578321
GO:0042981∼regulation of apoptosis 6 11.76% 0.011146801
GO:0048468∼cell development 9 17.65% 0.011636545
GO:0043067∼regulation of programmed
cell death
6 11.76% 0.011655337
GO:0006796∼phosphate metabolic process 8 15.69% 0.014311992
GO:0008219∼cell death 7 13.73% 0.017712167
Differentially expressed genes in siFoxm1-transfected HAVSMC cells were functionally
classiﬁed according to Gene Ontology (GO). Gene Ontology analysis was performed
using DAVID (database for annotation, visualization, and integrated discovery).
Table 4
Gene expression proﬁle of HAVSMC cells treated with Foxm1-speciﬁc siRNA.
Gene name GenBank
number
siFoxm1/
control
Transcription factors and cell cycle regulators
Forkhead box M1 (FoxM1) NM_021953 0.10
Centromere protein A NM_001809 0.13
Cyclin B1 N90191 0.14
Protein regulator of cytokinesis 1 NM_003981 0.17
Cyclin-dependent kinase inhibitor 3
(CDK2-associated dual speciﬁcity phosphatase)
AF213040 0.17
Polo-like kinase 4 (Plk4) AL043646 0.24
S-phase kinase-associated protein 2 (p45 or Skp2) BG105365 0.25
CDC20 cell division cycle 20 NM_001255 0.27
Cyclin A2 NM_001237 0.28
G2 and S-phase expressed 1 NM_016426 0.28
Cyclin E2 NM_004702 0.29
Cell division cycle 2 (cdc2 or cdk1) D88357 0.29
Centromere protein F NM_005196 0.30
Aurora kinase B AB011446 0.31
Baculoviral IAP repeat-containing 5 (survivin) BQ021146 0.31
Polo-like kinase 1 (Plk1) NM_005030 0.42
c-Jun N-terminal kinase (JNK1) AB005663 0.45
c-Myc transcription factor AY294976 0.50
Receptors, structural, and Intracellular
intracellular signaling proteins
CD36 antigen (collagen type I receptor,
thrombospondin receptor)
W95035 0.20
Retinoic acid receptor, alpha AJ417079 0.20
Calmodulin 1 (phosphorylase kinase, delta) AI653730 0.29
Interferon (alpha, beta, and omega) receptor 1 AA811138 0.33
Calcium/calmodulin-dependent protein kinase IV AL529104 5.3
Low density lipoprotein receptor-related protein 11 AK021807 3.71
Extracellular cell signaling and Secreted proteins
A disintegrin and metalloproteinase domain 10 AU135154 0.33
Placental growth factor BC001422 2.70
HAVSMC cells were transfected with Foxm1-speciﬁc siRNA (siFoxm1) and then
harvested at 72 hr after transfection. Total RNA was prepared from either siFoxm1-
transfected or mock-transfected cells (3 cell cultures were used for each group) and
then used for Affymetrix microarray. Values represent a fold change in RNA expression
of siRNA-transfected cells compared to mock-transfected cells. Genes in normal type
exhibited diminished expression in Foxm1-deﬁcient cells, and genes in italic type
displayed increased expression in Foxm1-deﬁcient cells.
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in Foxm1mRNA levels was observed in siFoxm1-transfected HAVSMC
cells (Table 4). A subset ofmRNAs, whose expressionwas decreased in
Foxm1-depleted cells, included centromere proteins A and F, cyclin B1,
aurora B kinase, polo-like kinases (Plk) 1 and 4, JNK1, and cyclin-
dependent kinase 1 (cdk1). Since these genes regulate G2/M transition
of the cell cycle and are required for cytokinesis (Glover et al., 1998;
Adams et al., 2001; Wang et al., 2008), their diminished levels can
contribute to the cell cycle defects seen in Foxm1-depleted HAVSMC
cells. Interestingly, numerous genes essential for G1/S transition were
also decreased in siFoxm1-transfected HAVSMC cells (Table 4). These
include cyclins A2, D1 and E2, c-Myc transcription factor, cdk2-
inhibitor 3, and S-phase kinase-associated protein 2 (Skp2), the latter
of which is a speciﬁcity subunit of the Skp1-Cullin 1-F-box (SCF)
ubiquitin ligase complex that targets both p21 (Cip1) and p27 (Kip1)
Cdk2 inhibitors for degradation during G1/S transition (Kossatz et al.,
2004). Signiﬁcantly decreased mRNA levels of IAP repeat-containing
survivin protein, a known transcriptional target of Foxm1 (Gusarova
et al., 2007), were found in siFoxm1-transfected cells (Table 4).We also
found several new genes, expression of which was altered in siFoxm1-
transfected HAVSMC cells. These include calmodulin 1, retinoic acid
receptor α, interferon receptor 1, collagen type I receptor, placental
growth factor, ADAM 10 protein, and other genes required for
extracellular and intracellular signaling (Table 4). Altogether, these
results suggest that Foxm1 directly or indirectly regulates expression of
numerous cell cycle regulators, receptors, enzymes, and adaptor
proteins.
In order to verify gene expression levels in siFoxm1-transfected
HAVSMC cells, quantitative real-time RT–PCR (qRT–PCR) was per-
formed using primers speciﬁc to several Foxm1 target genes
(Table 1). Approximately 10-fold reduction in Foxm1 mRNA levels
was observed in siFoxm1-transfected HAVSMC cells when compared
to either untransfected cells or HAVSMC cells transfected with
mutant siRNA (Fig. 7A). Consistent with Affymetrix microarray ana-
lysis (Table 4), Foxm1 depletion signiﬁcantly decreased mRNA levelsof cyclin B1, cyclin D1, Plk1, JNK1, and cMyc (Fig. 7A). Interestingly,
decreased expression of the same genes was found in G0/G1
population of HAVSMC cells isolated by ﬂow cytometry-based cell
sorting (Fig. 7A), indicating that Foxm1 regulates expression of these
genes prior to DNA replication. In G2/M population of sorted
HAVSMC cells, Foxm1 depletion was associated with decreased
mRNAs of cyclin B1, Plk1 and JNK1, whereas expression of cyclin D1
and cMyc was not signiﬁcantly changed (Fig. 7A). Interestingly,
Foxm1 depletion did not induce apoptosis in the cultured HAVSMC
cells (data not shown).
Finally, to determine whether Foxm1 regulates expression of the
same cell cycle regulatory genes in vivo, we used a laser capture
microdissection of frozen E16.5 sections to isolate total RNA from
developing aortas of smFoxm1−/− and control Foxm1ﬂ/ﬂ embryos
(Fig. 7B). Expression levels of the same cell cycle regulatory genes
were determined by qRT–PCR analysis. While these RNA samples
contained contributions from both the muscle and non-muscle cells
(endothelium, pericytes, and ﬁbroblasts), mRNA levels of Foxm1
were signiﬁcantly decreased in smFoxm1−/− aortas (Fig. 7C). While
cyclin D1 mRNA was not changed in smFoxm1−/− aortas, mRNAs of
cyclin B1, JNK1, cMyc, and M phase-promoting Cdc25B phosphatase
were signiﬁcantly decreased (Fig. 7C), indicating that Foxm1
induces expression of the cell cycle regulatory genes in vivo.
Taken together, these data suggest that Foxm1 depletion inhibits
cellular regulatory pathways that stimulate smooth muscle cell
proliferation during embryonic vascular development.
Fig. 7. Foxm1-deﬁcient smooth muscle cells displayed reduced expression of cyclin B1, c-Myc, JNK1, and Cdc25B phosphatase. (A) siRNA transfection in HAVSMC cells shows
decreased expression of cell cycle regulatory genes. HAVSMC cells were mock-transfected (control), transfected with siFoxm1 (siFoxm1), or transfected with mutant siRNA for 72 hr
and then used for preparation of total RNA (left panel). In separate experiments, cells in G0/G1 and G2/M phases were isolated using ﬂow cytometry and then used to prepare RNA
(right panel). qRT–PCR shows decreasedmRNAs of Foxm1, cyclins B1 and D1, Plk1, c-Myc, and JNK1 kinase in siFoxm1 transfected cells. Each individual sample was normalized to its
corresponding β-actin level. (B) Images of frozen sections show isolation of aortic tissues of E16.5 embryos by a laser capture microdissection. (C) Aortic tissues from smFoxm1−/−
and control Foxm1ﬂ/ﬂ embryos were used for preparation of total RNA. qRT–PCR analysis was performed with primers speciﬁc to Foxm1, cyclins B1 and D1, c-Myc, JNK1, and Cdc25B
phosphatase. Each individual sample was normalized to its corresponding β-actin level. Values are means±SD. A statistically signiﬁcant P valueb0.05 is shown with asterisk.
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The requirement for Foxm1 activity in smooth muscle cells was
examined in smFoxm1−/−mice that contain a smoothmuscle-speciﬁc
deletion of exons 4 through 7, encoding the Foxm1 DNA binding
domain and C-terminal transcriptional activation domains, both of
which are essential for Foxm1 transcriptional activity (Krupczak-
Hollis et al., 2004). Most of the smFoxm1−/− mice exhibited a
perinatal lethality within the ﬁrst 24 hr after birth because of severe
pulmonary hemorrhage and structural defects in arterial wall and
esophagus. Although Foxm1 deletion did not inﬂuence differentiation
of smoothmuscle cells, decreased proliferation of smoothmuscle cellswas found in smFoxm1−/− blood vessels and esophagus. Proliferation
defects in smFoxm1−/− embryos were associated with decreased
expression of M phase-promoting Cdc25B phosphatase and cyclin B1.
Progression into mitosis requires the activation of Cdk1 through
assembly with cyclin B1 regulatory subunit and the removal of Cdk1
inhibitory phosphates at Thr 14 and Tyr 15 by the Cdc25B and Cdc25C
phosphatases (Borgne and Meijer, 1996; Wells et al., 1999; Nilsson
and Hoffmann, 2000). Therefore, diminished levels of Cdc25B and
decreased levels of cyclin B1 can decrease Cdk1 activation and M
phase progression causing delayed entry into mitosis in Foxm1-
deﬁcient smooth muscle cells. These results are consistent with
previous studies that reported a direct transcriptional activation of
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(MEFs) and U2OS human osteosarcoma cell line (Wang et al., 2005a).
Our studies demonstrated that several genes critical for G1/S
transition were decreased in Foxm1-deﬁcient smooth muscle cells in
vivo and in vitro. These include JNK1, c-Myc transcription factor and
cyclins A2, D1, and E2 that activate Cdk proteins during G1/S
transition. Cdk2 complexes with either cyclin E or cyclin A cooperate
with cyclin D–Cdk4/6 to phosphorylate the retinoblastoma (RB)
protein, which releases bound E2F transcription factor and allows it to
stimulate expression of genes required for DNA replication (Harbour
and Dean, 2000; Ishida et al., 2001). Therefore, defects in cell
proliferation in smFoxm1−/− smooth muscle cells may be a direct
consequence of reduced Cdk2 and Cdk4 activity causing diminished
DNA replication. Our results are consistent with previously published
data demonstrating that transgenic overexpression of Foxm1 in
Rosa26-Foxm1 transgenic mice is associated with premature DNA
replication in pulmonary smooth muscle cells following butylated
hydroxytoluene (BHT) lung injury (Kalinichenko et al., 2003).
In our previous studies, we generated mice with global deletion of
the Foxm1 gene (homozygous for Foxm1 null allele or Foxm1−/−
mice) and demonstrated that these mice displayed an embryonic
lethal phenotype between E13.5 and E16.5 (Krupczak-Hollis et al.,
2004; Kim et al., 2005a; Ramakrishna et al., 2007). Foxm1−/−
embryos displayed multiple abnormalities in the development of
embryonic heart, liver, lung, and blood vessels as well as differentia-
tion defects in capillary endothelial cells (Kim et al., 2005a) and bile
duct epithelial cells (Krupczak-Hollis et al., 2004). However, since
Foxm1 is required for normal development of distinct Foxm1−/− cell
lineages, these studies did not clarify speciﬁc requirements for Foxm1
activity in smooth muscle cells. Furthermore, severe ventricular
hypoplasia in Foxm1−/− embryos may cause a diminished circulatory
output and altered signaling, causing secondary defects in developing
blood vessels. In this study, we demonstrated that Foxm1 deletion
from smFoxm1−/− smooth muscle cells is sufﬁcient to disrupt
vascular development in the absence of structural heart abnor-
malities. Therefore, Foxm1 promotes embryonic vascular develop-
ment by directly inﬂuencing proliferation of developing smooth
muscle cells. Interestingly, although increased apoptosis was
observed in smFoxm1−/− newborn mice, the apoptosis was not signi-
ﬁcantly increased in smFoxm1−/− embryos prior to birth. These
results raise a possibility that the apoptotic phenotype in smFoxm1−/−
micewas an indirect consequence of Foxm1deﬁciency. Furthermore, a
speciﬁc Foxm1 depletion by siRNA did not cause apoptosis in cultured
smooth muscle cells, providing further support for this concept.
In contrast to structural defects in smFoxm1−/− blood vessels, no
structural abnormalities were found in the developing airways,
stomach, or intestine of the smFoxm1−/− embryos. These results are
surprising and suggest different requirements in Foxm1 function in
different populations of developing smooth muscle cells. Published
studies demonstrated that vascular and visceral smooth muscle cells
(intestinal, esophageal, and peribronchial muscle) use distinct trans-
cription factor complexes to activate smooth muscle-speciﬁc gene
promoters. Differential deletion of the serum response factor (SRF)
binding sites (CArG boxes) revealed fundamental differences in
importance of particular SRF-binding regions between smoothmuscle
subtypes (Manabe and Owens, 2001). It was also demonstrated that
promoter of CRP-1 gene contains a CArG box-dependent enhancer,
which directs expression in arterial but not venous or visceral smooth
muscle cells (Lilly et al., 2001). Expression of GATA-5 and Foxf1
transcription factors was found to be restricted to visceral smooth
muscle cells with little or no expression in vascular smooth muscle
tissues (Morrisey et al., 1997; Kalinichenko et al., 2001). Selective
smooth muscle defects in smFoxm1−/− embryos indicate that
Foxm1 may regulate distinct genes in different subsets of smooth
muscle cells. However, molecular mechanisms underlying this
selectivity remain unknown. Alternatively, it is possible thatFoxm1 deletion does not efﬁciently occur in all smooth muscle
tissues during embryogenesis. While Cre recombinase protein was
detected in inner circumferential muscle layers of the developing
stomach and intestine, no Cre staining was observed in outer
longitudinal layers of smFoxm1−/− intestine until E18.5. In
contrast, smFoxm1−/− esophagi contained Cre protein in both
inner and outer smooth muscle layers. Interestingly, approximately
13% of smFoxm1−/− mice survived after birth and developed a
megacolon by 4 weeks of age (data not shown). Since a histo-
logical structure of the intestine in these adult smFoxm1−/− mice
was normal (data not shown), the megacolon may be a result of
diminished muscular tone and/or intestinal contractility in these
Foxm1 mutant mice.
In summary, smFoxm1−/−mice died immediately after birth due to
severe pulmonary hemorrhage, structural defects in arterial wall, and
esophageal abnormalities. Although Foxm1 deletion did not inﬂuence
differentiation of smoothmuscle cells, decreased cellular proliferation
was observed in muscle layers of embryonic blood vessels and
esophagus. Depletion of Foxm1 in vitro and in vivo was associated
with reduced expression of genes required for cell cycle progression.
The identiﬁcation of critical regulators of myocyte proliferation, such
as Foxm1, may provide novel strategies for diagnosis and treatment of
congenital vascular and esophageal abnormalities.
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